SecSonar.com

Sol-Gel Technologies Ltd. (SLGL)

Sol-Gel Technologies Ltd. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Sol-Gel Technologies Ltd. (SLGL) is a Biotechnology company based in IL with a market capitalization of $225.3M. Revenue grew 68.0% year-over-year and the company generated $275K in free cash flow. This page tracks SLGL's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

IL · 34 employees · IPO Feb 1, 2018

Valuation

Valuation & price

$76.73 · as of May 23, 2026 · -21.7% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

9.88

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$91.58$49.44$7.29Jul 25Dec 25Jun 26Jul 7, 25$7.29Jul 9, 25$7.38Jul 11, 25$8.14Jul 15, 25$8.02Jul 17, 25$8.41Jul 21, 25$8.42Jul 23, 25$9.94Jul 25, 25$11.00Jul 29, 25$12.00Jul 31, 25$12.60Aug 4, 25$13.42Aug 6, 25$13.44Aug 8, 25$15.99Aug 12, 25$15.25Aug 14, 25$15.25Aug 18, 25$16.10Aug 20, 25$18.40Aug 22, 25$22.67Aug 27, 25$21.95Aug 29, 25$22.79Sep 3, 25$23.40Sep 5, 25$27.96Sep 9, 25$25.93Sep 11, 25$24.08Sep 15, 25$23.98Sep 17, 25$24.35Sep 19, 25$30.50Sep 23, 25$28.81Sep 25, 25$27.99Sep 29, 25$28.74Oct 1, 25$29.50Oct 3, 25$34.80Oct 7, 25$40.99Oct 9, 25$39.65Oct 13, 25$39.95Oct 16, 25$40.51Oct 20, 25$39.83Oct 22, 25$39.10Oct 24, 25$39.00Oct 28, 25$36.85Oct 30, 25$37.00Nov 3, 25$35.50Nov 5, 25$32.70Nov 7, 25$30.63Nov 11, 25$31.88Nov 13, 25$35.58Nov 17, 25$36.00Nov 19, 25$36.04Nov 21, 25$36.65Nov 25, 25$40.39Nov 28, 25$42.42Dec 2, 25$38.73Dec 5, 25$40.50Dec 9, 25$40.13Dec 11, 25$42.30Dec 15, 25$42.77Dec 17, 25$41.15Dec 19, 25$42.16Dec 23, 25$43.17Dec 26, 25$41.85Dec 30, 25$42.46Jan 2, 26$42.15Jan 6, 26$45.96Jan 8, 26$55.68Jan 12, 26$62.99Jan 14, 26$67.79Jan 16, 26$69.50Jan 21, 26$63.01Jan 23, 26$58.44Jan 28, 26$63.50Jan 30, 26$64.22Feb 3, 26$66.10Feb 5, 26$64.70Feb 9, 26$65.27Feb 11, 26$66.10Feb 13, 26$67.20Feb 18, 26$81.01Feb 20, 26$83.98Feb 24, 26$87.63Feb 26, 26$89.15Mar 2, 26$91.58Mar 4, 26$88.40Mar 6, 26$81.65Mar 10, 26$88.70Mar 12, 26$85.31Mar 16, 26$76.04Mar 19, 26$81.71Mar 23, 26$66.20Mar 25, 26$79.07Mar 27, 26$79.20Mar 31, 26$79.22Apr 2, 26$79.46Apr 7, 26$71.11Apr 9, 26$72.02Apr 13, 26$74.41Apr 15, 26$79.80Apr 17, 26$73.87Apr 21, 26$75.89Apr 23, 26$72.30Apr 27, 26$77.00Apr 29, 26$71.40May 1, 26$75.61May 5, 26$73.77May 8, 26$70.86May 12, 26$67.21May 14, 26$68.68May 18, 26$68.35May 20, 26$65.29May 22, 26$76.73May 27, 26$73.80May 29, 26$73.86Jun 2, 26$73.73Jun 4, 26$74.37Jun 8, 26$80.00Jun 10, 26$73.50Jun 12, 26$73.44Jun 16, 26$72.87Jun 18, 26$74.46Jun 23, 26$71.26Jun 29, 26$74.41
$7.0152-week range$97.97
Loading valuation history…

Fundamentals

Key fundamentals

$225.3M

Market cap

68.0%

Revenue growth (YoY)

99.4%

Gross margin

$275K

Free cash flow (USD)

-$23M

Net debt

Net cash position

-90.0%

Share dilution

1/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$0.00FY 2017$174.0KFY 2018$129.0KFY 2019$22.9MFY 2020$8.8MFY 2021$31.3MFY 2022$3.9MFY 2023$1.6MFY 2024$11.5MFY 2025$19.4M
$0$19.4M

Free cash flow by year

2016 → 2025

FY 2016$-18.9MFY 2017$-26.0MFY 2018$-24.5MFY 2019$-23.1MFY 2020$-25.7MFY 2021$-7.8MFY 2022$-9.7MFY 2023$-17.9MFY 2024$-13.9MFY 2025$275.0K
-$18.9M$275K

Gross margin by year

2021 → 2025

FY 202134.8%FY 2022-226.6%FY 2023-1414.9%FY 202498.0%FY 202599.4%
34.8%99.4%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

3

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last reported: May 28, 2026 (EPS $-1.31)

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • Insider buyInsider Buy $123KOpaleye Management Inc. · 10% Owner · $123.2KJul 2, 2026Filing
  • Annual reportAnnual Report FiledMay 28, 2026Filing
  • Insider buyInsider Buy $101KOpaleye Management Inc. · 10% Owner · $100.7KMay 22, 2026Filing
  • Insider buyInsider Buy $232KOpaleye Management Inc. · 10% Owner · $231.5KMay 14, 2026Filing

Questions

Frequently asked questions

What is Sol-Gel Technologies Ltd.'s market cap?

Sol-Gel Technologies Ltd. (SLGL) has a market capitalization of $225.3M.

What is SLGL's P/E ratio?

A meaningful P/E ratio is not available for SLGL — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is SLGL's price-to-book (P/B) ratio?

SLGL trades at 9.88 times book value per share.

When did Sol-Gel Technologies Ltd. last report earnings?

SLGL last reported earnings on May 28, 2026; the next date is not yet scheduled.

Are insiders buying SLGL stock?

Yes — SEC Form 4 filings show 3 open-market insider buys and 0 sells at Sol-Gel Technologies Ltd. in the last 90 days.

Same arena

Related companies in Biotechnology

ARCT

Arcturus Therapeutics Holdings Inc.

$225.4M

YDES

YD Bio Limited Ordinary Shares

$223.1M

HUMA

Humacyte, Inc.

$222.6M

PRLD

Prelude Therapeutics Incorporated

$218.6M

WHWK

Whitehawk Therapeutics Inc

$232.4M

SGMT

Sagimet Biosciences Inc.

$235M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.